SAMD9L
Basic information
Region (hg38): 7:93130056-93148385
Previous symbols: [ "C7orf6" ]
Links
Phenotypes
GenCC
Source:
- ataxia-pancytopenia syndrome (Strong), mode of inheritance: AD
- ataxia-pancytopenia syndrome (Limited), mode of inheritance: AD
- ataxia-pancytopenia syndrome (Supportive), mode of inheritance: AD
- ataxia-pancytopenia syndrome (Definitive), mode of inheritance: AD
- spinocerebellar ataxia 49 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ataxia-pancytopenia syndrome; Monosomy 7 myelodysplasia and leukemia syndrome 1 | AD | Allergy/Immunology/Infectious; Hematologic; Oncologic | Ataxia-pancytopenia syndrome can include pancytopenia and related infectious risks, and awareness may allow prophylactic measures and early and aggressive treatment of infections and hematologic issues; Individuals have been descriebd with hematologic malignancies, and awareness may allow surveillance and prompt detection and management; Monosomy 7 myelodysplasia and leukemia syndrome 1 involves germline genetic anomaly as well as associated somatic loss of chromosome 7, and results in increased risk of hematologic malignancy such that awareness may allow early diagnosis and management of disease | Allergy/Immunology/Infectious; Hematologic; Neurologic; Oncologic | 283689; 27259050; 30046003; 30322869; 35310830 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Ataxia-pancytopenia syndrome (1 variants)
- Monosomy 7 myelodysplasia and leukemia syndrome 1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SAMD9L gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 217 | 230 | ||||
missense | 577 | 14 | 10 | 609 | ||
nonsense | 33 | 33 | ||||
start loss | 1 | |||||
frameshift | 32 | 36 | ||||
inframe indel | 11 | 11 | ||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 2 | 9 | 662 | 233 | 17 |
Variants in SAMD9L
This is a list of pathogenic ClinVar variants found in the SAMD9L region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-93131118-G-A | Likely benign (Jun 15, 2019) | |||
7-93131236-T-C | not specified | Uncertain significance (Sep 05, 2022) | ||
7-93131238-T-C | Likely benign (Sep 27, 2023) | |||
7-93131254-A-G | not specified • Inborn genetic diseases | Uncertain significance (Oct 13, 2023) | ||
7-93131254-A-T | Conflicting classifications of pathogenicity (Dec 06, 2023) | |||
7-93131264-C-A | Uncertain significance (Jul 19, 2022) | |||
7-93131279-CTCTT-C | Uncertain significance (May 11, 2022) | |||
7-93131293-C-A | Uncertain significance (Aug 24, 2023) | |||
7-93131295-A-G | Likely benign (Apr 23, 2022) | |||
7-93131304-G-A | Likely benign (Dec 14, 2023) | |||
7-93131307-T-A | Likely benign (Feb 05, 2022) | |||
7-93131311-C-G | SAMD9L-related disorder | Uncertain significance (Jan 04, 2024) | ||
7-93131318-A-T | Monosomy 7 myelodysplasia and leukemia syndrome 1 | Likely pathogenic (Nov 04, 2021) | ||
7-93131326-A-G | Uncertain significance (May 16, 2021) | |||
7-93131330-C-T | Uncertain significance (Oct 13, 2023) | |||
7-93131343-T-C | Likely benign (Oct 17, 2023) | |||
7-93131343-T-G | Uncertain significance (Jan 31, 2023) | |||
7-93131348-C-T | Uncertain significance (Jan 24, 2023) | |||
7-93131351-C-G | Uncertain significance (Jul 06, 2022) | |||
7-93131356-C-T | Uncertain significance (May 01, 2022) | |||
7-93131358-A-G | Likely benign (Jan 27, 2024) | |||
7-93131359-T-C | Uncertain significance (Aug 31, 2022) | |||
7-93131365-A-G | Uncertain significance (Aug 13, 2022) | |||
7-93131373-T-C | SAMD9L-related disorder | Likely benign (Nov 01, 2022) | ||
7-93131384-C-T | Uncertain significance (Aug 04, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SAMD9L | protein_coding | protein_coding | ENST00000318238 | 1 | 18315 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.57e-15 | 0.997 | 124982 | 1 | 755 | 125738 | 0.00301 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.63 | 661 | 790 | 0.836 | 0.0000385 | 10531 |
Missense in Polyphen | 159 | 196.97 | 0.80725 | 2746 | ||
Synonymous | -0.511 | 294 | 283 | 1.04 | 0.0000135 | 2889 |
Loss of Function | 2.86 | 32 | 54.9 | 0.583 | 0.00000297 | 761 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00325 | 0.00324 |
Ashkenazi Jewish | 0.00459 | 0.00457 |
East Asian | 0.000654 | 0.000653 |
Finnish | 0.00569 | 0.00556 |
European (Non-Finnish) | 0.00397 | 0.00388 |
Middle Eastern | 0.000654 | 0.000653 |
South Asian | 0.000915 | 0.000915 |
Other | 0.00247 | 0.00245 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in endosome fusion. Mediates down- regulation of growth factor signaling via internalization of growth factor receptors. {ECO:0000250|UniProtKB:Q69Z37}.;
Recessive Scores
- pRec
- 0.0905
Intolerance Scores
- loftool
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 50.56
Haploinsufficiency Scores
- pHI
- 0.122
- hipred
- N
- hipred_score
- 0.132
- ghis
- 0.514
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.252
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Samd9l
- Phenotype
- immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; neoplasm; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- endosomal vesicle fusion
- Cellular component
- cytoplasm;early endosome
- Molecular function
- protein binding